In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels.
Novel hydrogel materials based on oligo(poly(ethylene glycol) fumarate) (OPF) crosslinked with a redox radical initiation system were recently developed in our laboratory as injectable cell carriers for orthopedic tissue engineering applications. The effect of OPF hydrogel material properties on in vitro osteogenic differentiation of encapsulated rat marrow stromal cells (MSCs) with and without the presence of osteogenic supplements (dexamethasone) was investigated. Two OPF formulations that resulted in hydrogels with different swelling properties were used to encapsulate rat MSCs (seeding density approximately 13 million cells/mL, samples 6 mm diameter x 0.5 mm thick before swelling) and osteogenic differentiation in these constructs over 28 days in vitro was determined via histology and biochemical assays for alkaline phosphatase, osteopontin and calcium. Evidence of MSC differentiation was apparent over the culture period for samples without dexamethasone, but there was large variability in calcium production between constructs using cells of the same source. Differentiation was also seen in samples cultured with osteogenic supplements, but calcium deposition varied depending on the source pool of MSCs. By day 28, osteopontin and calcium results suggested that, in the presence of dexamethasone, OPF hydrogels with greater swelling promoted embedded MSC differentiation over those that swelled less (43.7 +/- 16.5 microg calcium/sample and 16.4 +/- 2.8 microg calcium/sample, respectively). In histological sections, mineralized areas were apparent in all sample types many microns away from the cells. These experiments indicate that OPF hydrogels are promising materials for use as injectable MSC carriers and that hydrogel swelling properties can influence osteogenic differentiation of encapsulated progenitor cells.
Temenoff
Johnna S
JS
Department of Bioengineering, Rice University, 6100 Main, Houston, Texas 77251, USA.
Park
Hansoo
H
Jabbari
Esmaiel
E
Sheffield
Tiffany L
TL
LeBaron
Richard G
RG
Ambrose
Catherine G
CG
Mikos
Antonios G
AG
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001672:Biocompatible Materials; D001854:Bone Marrow Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002452:Cell Count; D002454:Cell Differentiation / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D020100:Hydrogels; D066298:In Vitro Techniques; D008297:Male; D008422:Materials Testing; D010012:Osteogenesis / Q000187:drug effects; D053495:Osteopontin; D011091:Polyesters; D011092:Polyethylene Glycols; D051381:Rats; D017208:Rats, Wistar; D012795:Sialoglycoproteins / Q000378:metabolism; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
D001672:Biocompatible Materials; D020100:Hydrogels; D011091:Polyesters; D012795:Sialoglycoproteins; C506897:Spp1 protein, rat; C469550:oligo(poly(ethylene glycol)fumarate); D053495:Osteopontin; D011092:Polyethylene Glycols; D003907:Dexamethasone; D000469:Alkaline Phosphatase; D002118:Calcium